Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/1/2021
SIETES contiene 93213 citas

 
 
 1 a 20 de 567 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Logunov DY, Dolzhikova IV, Tukhvatulin AI, Shcheblyakov DV. Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply. Lancet 2020;396:3 de octubre. [Ref.ID 103738]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Bucci E, Andreev K, Björkman A, Calogero RA, Carafoli E, Carninci P, Castagnoli P, Cossarizza A, Musini C, Guerin P, Lipworth B, Sbardella G, Stocki T, Tuosto L, van Tulleken C, Viola A. Safety and efficacy of the Russian COVID-19 vaccine: more information needed. Lancet 2020;396:21 de septiembre. [Ref.ID 103737]
3.Enlace a cita originalTiene citas relacionadas Cita con resumen
Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott AB, Flach B, et al for the mRNA-1273 Study Group. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med 2020;383:17 de diciembre. [Ref.ID 103729]
4.Tiene citas relacionadas Cita con resumen
Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatulin AI, Shcheblyakov DV, Dzharullaeva AS, et al.. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. Lancet 2020;396:26 de septiembre. [Ref.ID 103724]
5. Cita con resumen
6. Cita con resumen
Corbella J. La primera vacuna de la Covid ensayada en personas muestra eficacia. La Vanguardia 2020:19 de mayo. [Ref.ID 103619]
7.Enlace a cita original Cita con resumen
Garcez H, Fernandes C, Barbosa F, Pereira MR, Silveira C, Marques-Texeira J. Effects of benzodiazepines administration on identification of facial expressions of emotion: a meta-analysis. Psychopharmacology (Berl) 2019:noviermbre. [Ref.ID 103227]
8.Enlace a cita original Cita con resumen
Matta MK, Zusterzeel R, Pilli NR, Patel V, Volpe DA, Florian J, Oh L, Bashaw E, Zineh I, Sanabria C, Kemp S, Godfrey A, Adah S, Coelho S, Wang J, Furlong L-A, Ganley C, Michele T, Strauss DG. Effect of sunscreen application under maximal use conditions on plasma concentration of sunscreen active ingredients. A randomized clinical trial. JAMA 2019:6 de mayo. [Ref.ID 103109]
9.Enlace a cita original Cita con resumen
Bafeta A, Koh M, Riveros C, Ravaud P. Harms reporting in randomized controlled trials of interventions aimed at modifying microbiota: a systematic review. Ann Intern Med 2018;169:240-7. [Ref.ID 102815]
10. Cita con resumen
11.Enlace a cita original
Pfeffer MA, McMurray JJV. Lessons in uncertainty and humility — Clinical trials involving hypertension. N Engl J Med 2016;375:1756-66. [Ref.ID 100966]
12. Cita con resumen
13. Cita con resumen
Moore N. Lessons from the fatal French study BIA-10-2474. BMJ 2016;353:i2727. [Ref.ID 100424]
14. Cita con resumen
Casassus B. New report on drug trial disaster in France. Lancet 2016;387:2187. [Ref.ID 100334]
15.Enlace a cita original
Kim H-S, Lim Y, Oh M, Ghim J-I, Kim E-Y, Kim DH, Shin J-G. The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes. Br J Clin Pharmacol 2016;81:301-12. [Ref.ID 100147]
16.Tiene citas relacionadas Cita con resumen
Gotzsche PC. Author’s reply to Dubicka and colleagues and Stone. BMJ 2016;352:i915. [Ref.ID 100054]
17. Cita con resumen
Casassus B. France releases interim report on drug trial disaster. Lancet 2016;387:634-5. [Ref.ID 100049]
18. Cita con resumen
Casassus B. France investigates drug trial disaster. Lancet 2016;387:326. [Ref.ID 99978]
19. Cita con resumen
Anónimo. One dead, five hospitalized in French clinical trial. DIA Daily 2016:19 de enero. [Ref.ID 99970]
20. Cita con resumen
Glund S, Stangier J, Schmohl M, Gansser D, Norris S, Van Ryn J, Lang B, Ramael S, Moschetti V, Gruenenfelder F, Reilly P, Kreuzer J. Articles Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial. Lancet 2015;386:680-90. [Ref.ID 99494]
Seleccionar todas
 
 1 a 20 de 567 siguiente >>